dextrothyroxine has been researched along with Black Fever in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bandeira, RS; Bueno, LL; Cardoso, JMO; Chávez-Fumagalli, MA; Coelho, EAF; Freitas, CS; Fujiwara, RT; Lage, DP; Ludolf, F; Machado, AS; Martins, VT; Oliveira-da-Silva, JA; Pereira, IAG; Ramos, FF; Reis, TAR; Roatt, BM; Tavares, GSV; Vale, DL | 1 |
Antinarelli, LMR; Brito, RCF; Chávez-Fumagalli, MA; Coelho, EAF; Coimbra, ES; Costa, RR; Freitas, CS; Humbert, MV; Lage, DP; Ludolf, F; Machado, AS; Martins, VT; Mendonça, DVC; Oliveira-da-Silva, JA; Ramos, FF; Reis, TAR; Roatt, BM; Silva, AM; Tavares, GSV | 1 |
Morsy, TA; Rasheid, KA | 1 |
3 other study(ies) available for dextrothyroxine and Black Fever
Article | Year |
---|---|
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Drug Repositioning; Humans; Interleukin-12; Ivermectin; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Micelles | 2023 |
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Erythrocytes; Female; Humans; Immunoglobulin G; Inhibitory Concentration 50; Ivermectin; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Reactive Oxygen Species; Spleen | 2021 |
Efficacy of ivermectin on the infectivity of Leishmania major promastigotes.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Ivermectin; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Mesocricetus | 1998 |